In a first step toward FDA approval of kidney xenotransplantation, a living human with end-stage kidney disease may receive a ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

Objectives To estimate the prevalence of maternal substance use problems during the first 1000 days of children’s lives, to inform planning and resourcing of antenatal screening and substance use in ...